Ipsilateral arterial access for management of vascular complication in transcatheter aortic valve implantation

Catheterization and Cardiovascular Interventions

Volumn 81, Issue 4, 2013, Pages 592-602

  Frerker, Christian ^a   Schewel, Dimitry ^a   Kuck, Karl Heinz ^a   Schäfer, Ulrich ^a  

^a DEPARTMENT OF CARDIOLOGY   (Germany)

Author keywords

aortic stenosis; complications; TAVI; vascular access

Indexed keywords

CONTRAST MEDIUM;

ACUTE KIDNEY FAILURE; ADULT; AGED; AORTA DISSECTION; AORTA VALVE PROSTHESIS; AORTA VALVE STENOSIS; ARTERY PUNCTURE; ARTICLE; BALLOON DILATATION; CONTROLLED STUDY; FEMALE; FEMORAL ARTERY; FOLLOW UP; HEART TAMPONADE; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERICARDIOCENTESIS; STENT; TRANSCATHETER AORTIC VALVE IMPLANTATION; VASCULAR ACCESS; VASCULAR DISEASE; VASCULAR SURGERY;

ACUTE KIDNEY INJURY; AGED; AGED, 80 AND OVER; AORTIC VALVE STENOSIS; CARDIAC CATHETERIZATION; CATHETERIZATION, PERIPHERAL; CONTRAST MEDIA; EQUIPMENT DESIGN; FEMALE; FEMORAL ARTERY; HEART VALVE PROSTHESIS IMPLANTATION; HEMORRHAGE; HEMOSTATIC TECHNIQUES; HUMANS; MALE; PUNCTURES; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; VASCULAR ACCESS DEVICES;

EID: 84874477076     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.24515     Document Type: Article

References (16)

1. Iung B, Baron G, Butchart EG, et al. A prospective survey of patients with valvular heart disease in Europe: The Euro heart survey on valvular heart disease. Eur Heart J 2003; 24: 1231-1243. (Pubitemid 36834640)
2. Bonow RO, Carabello BA, Kanu C, et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American heart association task force on practice guidelines (writing committee to revise the 1998 guidelines for the management of patients with valvular heart disease): Developed in collaboration with the society of cardiovascular anesthesiologists: Endorsed by the society for cardiovascular angiography and interventions and the society of thoracic surgeons. Circulation 2006; 114: e84-e231. (Pubitemid 44268973)
3. Kolh P, Kerzmann A, Honore C, Comte L, Limet R,. Aortic valve surgery in octogenarians: Predictive factors for operative and long-term results. Eur J Cardiothorac Surg 2007; 31: 600-606. (Pubitemid 46400496)
4. Smith CR, Leon MB, Mack MJ, et al. Transcatheter vs. surgical aortic valve replacement in high risk patients. N Engl J Med 2011; 364: 2187-2198.
5. Lefevre T, Kappetein AP, Wolner E, et al. One year follow-up of the multi-centre European PARTNER transcatheter heart valve study. Eur Heart J 2011; 32: 148-157.
6. Tamburino C, Capodanno D, Ramondo A, et al. Incidence and predictors of early and late mortality after transcatheter aortic valve implantation in 663 patients with severe aortic stenosis. Circulation 2011; 123: 299-308.
7. Leon MB, Piazza N, Nikolsky E, et al. Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials a consensus report from the valve academic research consortium. J Am Coll Cardiol 2011; 57: 253-269.
8. Sharp AS, Michev I, Maisano F, et al. A new technique for vascular access management in transcatheter aortic valve implantation. Catheter Cardiovasc Interv 2010; 75: 784-793.
9. Rodes-Cabau J, Webb JG, Cheung A, et al. Transcatheter aortic valve implantation for the treatment of severe symptomatic aortic stenosis in patients at very high or prohibitive surgical risk: Acute and late outcomes of the multicenter Canadian experience. J Am Coll Cardiol 2010; 55: 1080-1090.
10. Grube E, Laborde JC, Gerckens U, et al. Percutaneous implantation of the CoreValve self-expanding valve prosthesis in high-risk patients with aortic valve disease: The Siegburg first-in-man study. Circulation 2006; 114: 1616-1624. (Pubitemid 44547432)
11. Leon MB, Smith CR, Mack M, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 2010; 363: 1597-1607.
12. Gurvitch R, Toggweiler S, Willson AB, et al. Outcomes and complications of transcatheter aortic valve replacement using a balloon expandable valve according to the Valve academic research consortium (VARC) guidelines. EuroIntervention 2011; 7: 41-48.
13. Stähli BE, Bünzli R, Grünenfelder J, et al Transcatheter aortic valve implantation (TAVI) outcome according to standardized endpoint definitions by the valve academic research consortium (VARC). J Invasive Cardiol 2011; 23: 307-312.
14. Nuis RJ, Piazza N, Van Mieghem NM, et al. In-hospital complications after transcatheter aortic valve implantation revisited according to the valve academic research consortium definitions. Catheter Cardiovasc Interv 2011; 78: 457-467.
15. Hayashida K, Lefèvre T, Chevalier B, et al. Transfemoral aortic valve implantation new criteria to predict vascular complications. JACC Cardiovasc Interv 2011; 4: 851-858.
16. Sinning JM, Ghanem A, Steinhäuser H, et al. Renal function as predictor of mortality in patients after percutaneous transcatheter aortic valve implantation. JACC Cardiovasc Interv 2010; 3: 1141-1149.